FDA approves ABILIFY for acute bipolar mania, including manic and mixed episodes.
Publication: Life Science Weekly
Publication Date: 02-NOV-04
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Co. (BMY) and Otsuka Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has approved ABILIFY (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
The FDA approval...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
